78584-08-4 Usage
General Description
2-Benzothiazolamine,4,7-dimethyl-(9CI) is a chemical compound with the molecular formula C9H9NS. It is a derivative of benzothiazole, which is a heterocyclic compound containing a benzene ring fused to a thiazole ring. This specific derivative has two methyl groups attached at the 4 and 7 positions of the benzothiazole ring. It is used in the production of various organic compounds and can also be used as a building block in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals. The compound may also have potential applications in research and development, particularly in the field of organic synthesis and medicinal chemistry. Overall, 2-Benzothiazolamine,4,7-dimethyl-(9CI) is a versatile compound that can be utilized in a variety of chemical and pharmaceutical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 78584-08-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,8,5,8 and 4 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 78584-08:
(7*7)+(6*8)+(5*5)+(4*8)+(3*4)+(2*0)+(1*8)=174
174 % 10 = 4
So 78584-08-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H10N2S/c1-5-3-4-6(2)8-7(5)11-9(10)12-8/h3-4H,1-2H3,(H2,10,11)
78584-08-4Relevant articles and documents
POLY HETEROCYCLIC CONJUGATES AND THEIR PHARMACEUTICAL USES
-
, (2022/01/04)
Compounds of Formula (I) shown below and a pharmaceutical composition containing one of the compounds: Each of the variables is defined herein. Also disclosed is a method of treating a condition associated with uncontrolled cell growth with a compound of Formula (I).
Synthesis and biological activities of new 1,4-benzothiazine derivatives
Kajino,Mizuno,Tawada,Shibouta,Nishikawa,Meguro
, p. 2888 - 2895 (2007/10/02)
New 2H-1,4-benzothiazin-3(4H)-one derivatives possessing (4-phenyl-1-piperazinyl)alkyl moieties at the 2-position were synthesized and tested for calcium antagonistic and calmodulin antagonistic activities. Antihypertensive effects in spontaneously hypertensive rats were also evaluated. In general, these compounds were rather weak calcium channel blockers, although, in contrast, many of them had moderate to potent calmodulin antagonistic activity, and 2-[3-(4-(4-fluorophenyl)-1-piperazinyl]propyl]-2H-1,4-benzothiazin-3(4H )-one derivatives 45, 74 and 75 showed potent antihypertensive effects.
